Bio & Pharma
Medical IP's X-ray image analysis software certified as medical device
The S.Korean company plans to expand its software lineup to include the analysis of the heart, bone and blood vessels
By Mar 08, 2023 (Gmt+09:00)
1
Min read
Most Read
LG Chem to sell water filter business to Glenwood PE for $692 million


KT&G eyes overseas M&A after rejecting activist fund's offer


Mirae Asset to be named Korea Post’s core real estate fund operator


StockX in merger talks with Naver’s online reseller Kream


Meritz backs half of ex-manager’s $210 mn hedge fund



Medical IP, a South Korean medical AI company, has announced that its artificial intelligence (AI) medical image analysis software "TiSepX Lung Volumetry" has received Class 2 medical device certification from the Ministry of Food and Drug Safety.
The software calculates lung volume using chest X-rays and is the first TiSepX device to receive approval.
This is the first time that a TiSepX device, which uses AI to expand 2D X-rays into 3D images and then quantitatively analyzes organs, has been approved.
The lung volumetry device automatically analyzes lung volume data just by looking at X-rays, without the patient needing additional pulmonary function tests (PFT) or computed tomography (CT) scans. It is expected to be highly useful for diagnosing and monitoring interstitial lung disease and other similar conditions.
This certification is a significant milestone for Medical IP, which plans to expand its TiSepX lineup to include the analysis of the heart, bone and blood vessels.
Write to Ji-Hyun Lee at bluesky@hankyung.com
More to Read
-
Artificial intelligenceS.Korea's Lunit supplies breast cancer imaging solution to UAE
Feb 09, 2023 (Gmt+09:00)
1 Min read -
Bio & PharmaBridge Biotherapeutics, Pinotbio develop lung cancer treatment
Jan 27, 2023 (Gmt+09:00)
1 Min read -
Bio & PharmaLunit exports AI imaging analysis solution to Brazil
Dec 19, 2022 (Gmt+09:00)
1 Min read
Comment 0
LOG IN